Pune, 13 October 2025: Hikal Ltd., the preferred long-term partner for leading global life sciences companies, today announced the inauguration of its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at its Integrated Innovation Centre in Pune.
This world-class facility marks a significant milestone in Hikal’s innovation journey, further strengthening its end-to-end CDMO capabilities and enhancing its ability to safely develop and test and deliver highly potent compounds for the global pharmaceutical industry.
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements. The lab is purpose-built to support the development of complex oncology and specialty molecules, including components of Antibody Drug Conjugates (ADCs), Peptide Drug Conjugates (PDCs), and Proteolysis Targeting Chimeras (PROTACs).
“Our new HPAPI laboratory represents a critical step forward in expanding our capabilities and reinforcing our unwavering commitment to innovation, safety and customer excellence,” said Sameer Hiremath, Vice Chairman & Managing Director, Hikal Ltd. “With this new addition to our technology toolbox, we are well positioned to meet the growing demand for potent molecule development while maintaining the highest global standards of containment and compliance.”
Key Features of the Facility
The HPAPI Lab complements Hikal’s existing validation lab, process safety lab, solid state lab, flow chemistry lab, instrumentation and synthesis laboratories, creating a truly integrated innovation ecosystem at the Pune site. This ecosystem supports the seamless transition of projects, from early-phase studies to commercial manufacturing, covering scales from milligrams to >100 Kg batch size in our pilot plant.
With decades of experience in scaling molecules from clinical to commercial, Hikal continues to be a trusted partner for the pharmaceutical, animal health, and specialty chemicals industries, enabling the development and manufacture of APIs and AIs through innovation, flexibility, and best in class ESG.
About Hikal Limited
Established in 1988, Hikal is a reliable partner to companies in the Pharmaceutical, Animal Health, Biotech, Personal Care and Specialty Chemical industries. We manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology Innovation centre at Pune. Our facilities have been inspected and certified by Global Regulatory Authorities.
Hikal believes in inclusive growth that embraces all stakeholders. Hikal is one of the first Indian life-sciences company to receive the Responsible Care® certification. We accord the highestpriority to safety and health of our employees by adopting best practices in manufacturing.
